ABSTRACT PURPOSE: To evaluate the results of combined intracorneal ring (Keraring, Mediphacos Ltd) and anterior chamber, iris-fi xated, phakic intraocular lens (pIOL) (Artisan and Artifl ex, Ophtec BV) implantation in patients with ectatic corneal conditions and secondary high myopic and astigmatic refractive error.
METHODS: Ten eyes of eight consecutive patients with different ectatic corneal diseases underwent sequential intracorneal Keraring and iris-fi xated pIOL implantation. Two eyes with keratoconus, one eye with pellucid marginal degeneration, and one eye with iatrogenic corneal ectasia were implanted with the Artisan pIOL; six eyes with keratoconus were implanted with the Artifl ex pIOL. Uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), manifest refraction spherical equivalent (MRSE), topographic fi ndings, and complications were recorded.
RESULTS:
Mean UDVA improved from 0.02Ϯ0.10 preoperatively to 0.11Ϯ0.06 after Keraring implantation and to 0.54Ϯ0.18 after pIOL implantation (PϽ.001 for all). Mean CDVA improved from 0.18Ϯ0.12 preoperatively to 0.39Ϯ0.13 after Keraring implantation and to 0.66Ϯ0.18 after pIOL implantation (PϽ.001 for all). Mean MRSE reduced from Ϫ12.50Ϯ6.31 D preoperatively to Ϫ12.08Ϯ5.17 D after Keraring implantation (P=.10) and to Ϫ0.10Ϯ0.84 D after pIOL implantation (PϽ.001). No intra-or postoperative complications were observed. K eratoconus, pellucid marginal corneal degeneration, and corneal ectasia after LASIK are believed to share common pathophysiologic mechanisms and management options. 1 In their advanced stages, characterized by high myopia and irregular astigmatism, it is often impossible to correct the whole refractive error by a single procedure.
The bioptics approach is a sequential combination of different refractive techniques to treat large and complex refractive errors. 2, 3 The use of this approach in the management of refractive errors secondary to keratectasia has been reported previously, combining phakic intraocular lens (pIOL) implantation with Intacs intracorneal ring segments (Addition Technology Inc, Des Plaines, Ill). [4] [5] [6] The current study is the fi rst report in which intracorneal Keraring segment (Mediphacos, Belo Horizonte, Brazil) implantation was combined with iris-fi xated pIOL (Artisan and Artifl ex; Ophtec BV, Groningen, The Netherlands) implantation in patients with primary and secondary corneal ectatic conditions.
PATIENTS AND METHODS
Consecutive patients with different corneal ectatic diseases, who had been admitted to Turkiye Hospital Eye Clinic, were included in the study. All patients were intolerant to contact lens use and had clear corneas. Patients with corneal apical scarring, history of systemic diseases that may have an adverse effect on the cornea and ocular surface, or any ocular disease except corneal ectasia and related refractive error were excluded. If the pupil was not adequately constricted, acetylcholine was injected into the anterior chamber. The anterior chamber was fi lled with sodium hyaluronate 1.4% (Healon GV, AMO). The scleral tunnel was completed with a 45° diamond knife, at the previously marked site. The Artisan pIOL was inserted with a special forceps into the anterior chamber and was centered on the pupil. At the same time, an enclavation needle was inserted through one of the paracentesis sites to lift an approximately 1.0-mm iris fold and enclave it on the claws of the haptic. The same procedure was completed on the other haptic. A peripheral iridotomy was created either superonasally or superotemporally. Intracameral sodium hyaluronate was fl ushed to prevent postoperative intraocular pressure elevation. The scleral tunnel and overlying conjunctiva were then closed with 8-0 vicryl sutures (Ethicon Inc, Westwood, NJ). The Artifl ex implantation procedure was performed in the same way as the Artisan implantation procedure, except the folded pIOL was inserted through a 3.2-mm corneal self-sealing incision using a special forceps instead of creating a scleral tunnel.
All surgeries were completed uneventfully in all eyes. Postoperative management included topical ofl oxacin 0.3% four times a day (Exocin; Allergan, Mougins, France) and prednisolone acetate 1% four time a day (Predforte, Allergan). An eye-shield was placed to cover the eye of all patients. Patients were instructed to avoid eye rubbing and to use preservative-free artifi cial tears (Refresh Plus; Allergan, Irvine, Calif) six to eight times a day.
The UDVA, CDVA, spherical and cylindrical refractive error, and manifest refraction spherical equivalent (MRSE) parameters were analyzed preoperatively, after Keraring implantation before pIOL implantation, and at last follow-up. On the Orbscan corneal topographies, the minimum/maximum simulated keratometric readings and anterior/posterior difference values from the best-fi t sphere were recorded, and the values after Keraring implantation were compared to preoperative values. The Orbscan parameters after pIOL implantation were not included in the analysis, as scleral tunnel incisions and 3.2-mm corneal self-sealing incisions are expected to induce only minimal cylinder. 7, 8 The safety, safety index, the effi cacy, and effi cacy index were also assessed. Safety was defi ned as the number and percentage of eyes that did not lose more than two lines of CDVA. The safety index was defi ned as mean postoperative CDVA divided by mean preoperative CDVA. Effi cacy was defi ned as the number and percentage of eyes achieving UDVA Ͼ0.5 (decimal). The effi cacy index was defi ned as the mean postoperative UDVA divided by mean preoperative CDVA.
Statistical analysis was done using SPSS software, version 15.0 (SPSS Inc, Chicago, Ill). A one-way repeated measures of analysis of variance (ANOVA) test was used to analyze the change in each of the parameters at three different time points. If a parameter was signifi cantly changed, a protected dependent t test was performed as a post-hoc analysis. Paired sample t test was used to compare the pre-and postoperative parameters in each group. A P value Ͻ.05 was considered statistically signifi cant for repeated measures of ANOVA and paired sample t tests, and a P value Ͻ.017 was considered statistically signifi cant for post-hoc tests.
RESULTS
A total of 10 (7 right and 3 left) eyes of 8 patients were included in the study; 3 were women and 5 were men. Mean patient age was 31.00Ϯ7.01 years (range: 22 to 45 years).
Pre-and postoperative data for each eye are summarized in Table 1 . Eight eyes had keratoconus, one had iatrogenic corneal ectasia, and one had pellucid marginal corneal degeneration. Preoperatively, mean central and thinnest pachymetric readings were 375.0Ϯ65.90 µm (range: 313 to 508 µm) and 351.5Ϯ69.63 µm (range: 279 to 487 µm), respectively.
Characteristics of the implanted Keraring segments and pIOLs in each patient are summarized in Table 2 . Keraring segments were implanted as per manufacturer's The iris-fi xated pIOL implantation was performed 6.6Ϯ5.2 months (range: 3 to 18 months) after Keraring implantation. The Artisan pIOL was implanted in four eyes, and the Artifl ex was implanted in six eyes. Mean power of the implanted pIOL was Ϫ11.95Ϯ3.86 diopters (D) (range: Ϫ7.50 to Ϫ20.00 D). Patients were followed for 13.8Ϯ4.05 months (range: 12 to 24 months) after pIOL implantation. Postoperative slit-lamp image of an eye after 90° arc Keraring and Artifl ex pIOL implantation is shown in Figure 1 . Table 3 displays mean UDVA, CDVA, spherical and cylindrical refractive errors, and MRSE, at three different time points, and mean K readings and anterior and posterior difference from the best-fi t sphere values at two different time points. Orbscan II corneal topography before and after Keraring implantation is shown in Figures 2 and 3 .
A one-way repeated measures of ANOVA calculated comparing UDVA, CDVA, spherical/cylindrical refractive errors, and MRSE of patients at three time points demonstrated a signifi cant effect in all parameters (F(2,18)=86.3, PϽ.001). Follow-up protected t tests were performed to analyze the change in each of these parameters at different time points. The results revealed that both UDVA and CDVA increased signifi cantly after Keraring implantation compared to preoperatively, and after pIOL implantation compared to after Keraring implantation (PϽ.001 for all). The spherical refractive error and MRSE decreased signifi cantly after pIOL implantation (PϽ.001 for both) but not after Keraring implantation (P=.79 and P=.10, respectively). On the other hand, A paired sample t test was calculated comparing the mean K reading and anterior difference values from bestfi t sphere preoperatively and after Keraring implantation, and a signifi cant decrease in both parameters was found (P=.03 for both). However, a paired sample t test to compare the posterior difference values from best-fi t sphere preoperatively and after Keraring implantation did not reveal a signifi cant change (P=.63).
This study demonstrated 100% safety in both surgeries with no complications, including cataract, glaucoma, or clinically signifi cant endothelial compromise. The safety and effi cacy indices were 2.17 and 0.61 after Keraring implantation, respectively, and 1.69 and 1.38 after pIOL implantation, respectively. Overall, the safety index was 3.67 (ie, 267% gain in CDVA), effi cacy was 70%, and the effi cacy index was 3 (ie, fi nal mean UDVA of three times the preoperative mean CDVA).
Nine of the 10 eyes gained у3 lines of UDVA and CDVA, and 6 eyes achieved a fi nal CDVA of у0.7. In only 1 eye (eye 2), UDVA improved from counting fi ngers at 1.5 m to 0.2; CDVA did not change. In this patient, preoperative cylindrical refraction of Ϫ11.00 D decreased to Ϫ5.00 D postoperatively. A future astigmatic keratotomy will enhance further decrease in cylinder correction, with a possible improvement of CDVA.
DISCUSSION
In corneal ectatic conditions, laser refractive procedures are widely accepted to be contraindicated. 9 Collagen cross-linking treatment, which has been developed to address the problem of ectasia, does not create a signifi cant amount of refractive correction. 10 Bioptics techniques currently performed mostly involve pIOL implantation or refractive lens exchange combined with keratorefractive surgery. 11, 12 Colin and Velou 13 were fi rst to publish results of implantation of intracorneal rings and anterior chamber pIOL to correct refractive error in keratoconus. Other studies report pIOL implantation and Intacs intracorneal ring implantation in patients with keratoconus. [4] [5] [6] Intracorneal ring implantation aims to reshape and improve the topographic and optical properties of the cornea and to secondarily improve visual acuity. Its effi cacy in both primary and secondary keratectasias has been shown by several studies. 14, 15 The procedure is shown to be more effi cient in terms of refractive and optical correction in eyes with keratectasia compared to eyes with simple myopic refractive errors. 16 However, in the majority of cases, the whole refractive error is not corrected.
The intracorneal rings used in this study have small optic diameters of 5.0 mm. This property creates two advantages. First, because the intracorneal rings are implanted closer to the visual axis, the corneal fl attening effect is increased and the change in MRSE is greater. 17 Additionally, if refractive and visual outcome is unsatisfactory, future penetrating keratoplasty would be easier technically when the diameter of the implanted intracorneal ring segment is smaller compared to larger.
In eyes with keratectasia, the anterior chamber is generally wider than that in normal eyes and provides adequate space for implantation of anterior chamber pIOLs. We prefer iris-fi xation anterior chamber pIOLs, which do not cause damage to the angle structures, and have "one-size-fi ts-all" characteristics. Implantation of toric versions of the anterior chamber iris claw and posterior chamber implantable collamer lens (Visian ICL; STAAR Surgical, Monrovia, Calif) pIOLs have been performed successfully for the correction of high astigmatism. 4, 6, 18 In our opinion, the ICL pIOL seems to be the second line of choice due to limited potential space for its implantation and risk of capsu- The eyes enrolled in this study had high K readings, and high spherical/cylindrical errors that were either uncorrectable with only intracorneal ring implantation, or it was impossible to use the necessary ring thicknesses due to thin pachymetric readings. Four of the study eyes had been recommended for penetrating keratoplasty in other clinics (eyes 1, 3, 5, and 6). In two patients, the fellow eye had undergone penetrating keratoplasty (eyes 3 and 5); and in three eyes, the K reading exceeded 60.00 D (eyes 2, 3, and 4).
In this case series, all patients had increased UDVA and CDVA and decreased spherical and cylindrical refractive errors. These results are probably better than penetrating keratoplasty outcomes. The high K readings and irregular shape of the recipient cornea would create technical diffi culties in keratoplasty, and postoperative high astigmatism resulting in a less favorable visual acuity outcome would be a major issue. Considering the risk of graft rejection/graft failure and the required intensive postoperative care, preserving their own corneas seems to be in the patients' best interest. On the other hand, bioptics procedures with sequential intracorneal ring and pIOL implantation allow us to improve the corneal characteristics and visual acuity in eyes with corneal ectasia. For an experienced surgeon, both procedures are not diffi cult to perform. If a successful outcome is not obtained, the procedures are easily reversible and do not prevent future penetrating keratoplasty.
It is important to note that intracorneal ring implantation should always be performed fi rst, which corrects the refractive myopia and astigmatism in a limited manner. Also, the axis of astigmatism is likely to be changed postoperatively. Because postoperative outcomes of intracorneal ring implantation are often unpredictable in different stages of the ectatic disease, it is important to wait until the corneal edema disappears and the refractive error stabilizes before proceeding to the next step of the bioptics procedure.
The main drawback of this study is the lack of adequate postoperative endothelial cell density counts, especially after pIOL implantation, which would enable comparison with preoperative cell counts. However, we did not encounter any eyes with clinically apparent corneal decompensation. The aim of this study was to demonstrate the refractive and visual results of the bioptics approach with sequential intracorneal ring and pIOL implantation. The safety of each of these procedures with respect to endothelial cell count has been demonstrated previously. [19] [20] [21] Sequential intracorneal Keraring segments and Artisan/Artifl ex iris-fi xated pIOL implantation yielded satisfactory visual and refractive results and could be considered as an alternative to penetrating keratoplasty in patients with different corneal ectatic conditions with high myopic refractive errors. 
